CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts.
Diagnosed with asthma as a baby, Cole Schmidtknecht took the inhaler daily as a preventive medication since he was about 13, ...
The U.S. Department of Labor alleged wrongful denials for ER and urinary drug screening; Eden Prairie-based company says processes are no longer in place.
Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Shares were up after the ...
Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results